Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mymensingh Med J ; 31(4): 925-930, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36189534

RESUMO

Well established and common practice in conservative management of omphalocele major is escharotics therapy with different topical agents. Among them mercurochrome, alcohol, silver salts, povidone iodine, acacia nilotca paste are commonly used. It is a comparative study between application of acacia nilotica paste and povidone iodine solution as a primary non surgical treatment of omphalocele major regarding efficacy and safety of these two topical agents. A double blind randomized controlled study was conducted at the department of Paediatric Surgery, Mymensingh Medical College Hospital, Mymensingh, Bangladesh from July 2016 to June 2019. In this study 20 cases of omphalocele major and randomly divided into two equal groups. Group A and Group B treated with acacia nilotica paste and povidone iodine solution respectively. Gastroschisis, ruptured-omphalocele major or omphalocele minor excluded in this study. The size of the fascial defect in cm, time required for full oral feeding tolerance and duration of hospital stay were evaluating parameters. Patients with Group A tolerated full oral feeding earlier, shorter total hospital stay duration and low mortality rate than those from Group B. Application of acacia nilotica is a safe and effective treatment of omphalocele major regarding rapid full oral feeding tolerance, shorter hospital stay and low mortality rate.


Assuntos
Acacia , Anti-Infecciosos Locais , Hérnia Umbilical , Anti-Infecciosos Locais/uso terapêutico , Criança , Hérnia Umbilical/tratamento farmacológico , Hérnia Umbilical/cirurgia , Humanos , Merbromina/uso terapêutico , Povidona-Iodo/uso terapêutico , Sais/uso terapêutico , Prata/uso terapêutico
2.
J Int Adv Otol ; 15(1): 22-27, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30541727

RESUMO

OBJECTIVES: Topical treatment is first choice in the treatment of uncomplicated chronic otitis media. It was intended to assess auditory and histopathological safety of ototopical use of mercurochrome solution in rats with induced tympanic membrane perforation. MATERIALS AND METHODS: The study was conducted on 21 female Wistar-Albino rats which were randomly assigned into 3 groups. In all rats, perforation was performed at right tympanic membrane. Distortion product otoacoustic emissions (DPOAEs) measurements were performed at frequencies of 2000, 3000 and 4000 Hz (with L1/L2: 70 /70 dB at 2f1-f2 frequency; f2/f1 ratio: 1:22) before recovery from anesthesia and signal-to-noise ratio (SNR) were recorded. Normal saline, 2% mercurochrome and gentamicin were given to group 1, 2 and 3 twice daily over a week, respectively. Rats were sacrificed after DPOAE measurements on day 14. Right temporal bone specimens were examined under light microscope after processing. RESULTS: Based on DPOAE results, there was no significant difference among groups before treatment. On day 14, significant differences were found in DPOAE measurements at 3000 and 4000 Hz, and in mean SNR values in 2% mercurochrome and gentamicin groups when compared to normal saline group while no significant difference was detected at 2000 Hz among groups. In addition, significant degeneration was detected in Corti organs, spiral ganglions and stria vascularis in groups 2 and 3. CONCLUSION: In this study, it was observed that mercurochrome use in external otitis and otitis media with tympanic membrane perforation could cause ototoxicity and concluded that the solution should be used cautiously.


Assuntos
Audição/efeitos dos fármacos , Merbromina/efeitos adversos , Ototoxicidade/complicações , Perfuração da Membrana Timpânica/tratamento farmacológico , Membrana Timpânica/efeitos dos fármacos , Administração Tópica , Animais , Antibacterianos/administração & dosagem , Cóclea/efeitos dos fármacos , Cóclea/ultraestrutura , Feminino , Gentamicinas/administração & dosagem , Merbromina/administração & dosagem , Merbromina/uso terapêutico , Merbromina/toxicidade , Compostos Organomercúricos/uso terapêutico , Otite Externa/tratamento farmacológico , Otite Média/tratamento farmacológico , Distorção da Percepção/efeitos dos fármacos , Ratos , Ratos Wistar , Razão Sinal-Ruído
3.
J Dermatol ; 25(7): 469-75, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9714982

RESUMO

A sixty-year-old man, developed 2-5 mm sized, hyperemic, itchy papules, vesicles, erosions and crusts on hyperemic base on his chest, abdomen, back, gluteal region, and proximal sites of his upper and lower extremities. The direct and indirect immunoflurescence tests were negative. Histology revealed extensive acantholysis in the epidermis in the following forms: pemphigus vulgaris-like suprabasal acantholysis, Darier-like acantholytic dyskeratosis with corps ronds, Hailey-Hailey-like suprabasal clefts, and pemphigus foliaceus-like superficial acantholysis with spongiosis. Using systemic steroids, topical drying, and reepithelising therapy, the patient was cured. He was symptom-free the first, fourth, and thirteenth months after finishing steroid therapy. We review the literature and the new subdivision of the disease according to the histological and clinical features.


Assuntos
Acantólise/tratamento farmacológico , Anti-Inflamatórios/uso terapêutico , Glucocorticoides/uso terapêutico , Prednisolona/uso terapêutico , Acantólise/patologia , Anti-Infecciosos Locais/administração & dosagem , Anti-Infecciosos Locais/uso terapêutico , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/uso terapêutico , Doença de Darier/patologia , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/uso terapêutico , Epiderme/patologia , Técnica Direta de Fluorescência para Anticorpo , Técnica Indireta de Fluorescência para Anticorpo , Seguimentos , Humanos , Hiperemia/patologia , Ceratose/patologia , Masculino , Merbromina/administração & dosagem , Merbromina/uso terapêutico , Pessoa de Meia-Idade , Pênfigo/patologia , Pênfigo Familiar Benigno/patologia , Salicilatos/uso terapêutico
4.
J Clin Laser Med Surg ; 12(1): 27-9, 1994 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10151037

RESUMO

Argon laser therapy of superficial pigmented lesions in both young and old people is associated with a risk of complications including delayed wound closure and hypo/hypertrophic scarring. Problems may also occur after treatment of lesions located on the eyelid. To minimize the risk of these problems coagulation of deep tissue should be avoided. We discuss a technique using mercurochrome, a red-colored compound that absorbs the blue and green lines of the argon laser, as a barrier for the irradiated light that eliminates these complications and we provide probable reasons for this technique's effectiveness.


Assuntos
Terapia a Laser/métodos , Merbromina/uso terapêutico , Dermatopatias/terapia , Humanos , Terapia a Laser/efeitos adversos , Terapia a Laser/instrumentação , Resultado do Tratamento
5.
Surg Gynecol Obstet ; 172(5): 394-6, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1709307

RESUMO

Two management patterns were identified in 36 patients with exomphalos--primary surgical closure and initial topical therapy with delayed surgical closure. Primary surgical closure of minor exomphalos was well tolerated in 15 patients, but was associated with a high local and systemic morbidity rate in 14 patients with major defects. In contrast, initial topical therapy with silver sulphadiazine and delayed closure in seven matched patients with a major defect were well tolerated and did not prolong duration of hospitalization. Enteral feeding was more readily established and subsequent fascial closure facilitated in the conservatively treated group. It was suggested that this method should be more often considered in the management of all instances of major exomphalos.


Assuntos
Hérnia Umbilical/terapia , Administração Tópica , Terapia Combinada , Esquema de Medicação , Quimioterapia Combinada , Estudos de Avaliação como Assunto , Feminino , Hérnia Umbilical/complicações , Hérnia Umbilical/mortalidade , Humanos , Recém-Nascido , Merbromina/administração & dosagem , Merbromina/uso terapêutico , Reoperação , Estudos Retrospectivos , Sulfadiazina de Prata/administração & dosagem , Sulfadiazina de Prata/uso terapêutico
6.
Rev. goiana med ; 36(1/4): 55-9, jan.-dez. 1990. tab
Artigo em Português | LILACS | ID: lil-176520

RESUMO

Os autores realizaram um estudo comparativo de cinco preparados para uso tópico no tratamento de queimaduras. Foram tratadas 125 (cento e vinte e cinco) pacientes, divididos aleatoriamente em cinco grupos de 25 (vinte e cinco) pacientes cada. Os medicamentos empregados foram o merbromino a 2(pôr cento), salicilato de sódio, sulfadiazinato de zinco e a combinaçäo de colagenase com clorafenicol. No grupo IV foi feita uma associaçäo do salicilato de sódio e sulfadiazinato de zinco. A análise estatística dos resultados mostrou näo haver diferença significativa entre os diversos grupos, quando se toma em consideraçäo o tempo necessário para a completa epitelizaçäo das lesÆes


Assuntos
Humanos , Queimaduras/terapia , Cloranfenicol/uso terapêutico , Merbromina/uso terapêutico , Salicilato de Sódio/uso terapêutico , Zinco/uso terapêutico
8.
MMW Munch Med Wochenschr ; 121(5): 181-4, 1979 Feb 02.
Artigo em Alemão | MEDLINE | ID: mdl-84334

RESUMO

Since the end of 1974 we have used Betaisodona instead of Mercurochrome for Grob's three stage tanning because the harmful effects of the mercury contained in the Mercurochrome could not be excluded with certainty. The results were compared in 80 patients in each case. The two groups were comparable with regard to age, degree and extent of the burns. We obtained an equally firm and rapidly drying scab using Betaisodone as with Mercurochrome. Complete loosening of the scab took 16 days with Betaisodona and 14 days with Mercurochrome. Wound infection was no more frequent than with Mercurochrome disinfection.


Assuntos
Queimaduras/tratamento farmacológico , Iodo/uso terapêutico , Povidona/uso terapêutico , Administração Tópica , Adolescente , Criança , Pré-Escolar , Humanos , Lactente , Iodo/administração & dosagem , Merbromina/uso terapêutico , Povidona/administração & dosagem , Infecção dos Ferimentos/prevenção & controle
9.
Br J Surg ; 63(7): 523-5, 1976 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-60157

RESUMO

Ninety-six cases of exomphalos or gastroschisis managed at The children's Hospital, Sheffield, during the period 1964-74 are analysed. There were 306 cases with minor lesions, 30 with major lesions, 27 with a ruptured exomphalos and only 3 with gastroschisis. The overall mortality rate was 46-9 percent. Survival could be closely correlated with the birth weight, the nature of the primary lesion, the presence or absence of liver within the sac and the presence and severity of associated congenital anomalies. A "scoring system" based on these criteria is proposed to predict the prognosis of an infant with an exomphalos.


Assuntos
Músculos Abdominais/anormalidades , Hérnia Umbilical/congênito , Músculos Abdominais/cirurgia , Feminino , Hérnia Umbilical/cirurgia , Hérnia Umbilical/terapia , Humanos , Lactente , Recém-Nascido , Masculino , Merbromina/uso terapêutico , Elastômeros de Silicone/uso terapêutico
10.
Cor Vasa ; 18(1): 77-9, 1976.
Artigo em Inglês | MEDLINE | ID: mdl-57025

RESUMO

Premature ventricular contractions are relatively often encountered in patients after surgical treatment of ischaemic heart disease. Mercurascan (MSC), given at 0.05 mg/kg of body weight, favourably affected both the incidence and duration of arrhythmia. Unlike other antiarrhythmics, MSC did not affect the heart rate nor blood pressure. Postoperative treatment of ventricular arrhythmia with MSC is a promising procedure and merits further clinical and experimental investigation.


Assuntos
Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/tratamento farmacológico , Fluoresceínas/uso terapêutico , Merbromina/uso terapêutico , Complicações Pós-Operatórias/tratamento farmacológico , Arritmias Cardíacas/etiologia , Ponte de Artéria Coronária/efeitos adversos , Doença das Coronárias/cirurgia , Avaliação de Medicamentos , Humanos , Monitorização Fisiológica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA